We are excited to be one of the first to prescribe these FDA approved glasses for myopia control treatment. This will help to fill the gap for children who are unable to wear contacts and cannot tolerate side effects of alternative methods of myopia control such as atropine (i.e. sensitivity to light, blurred vision).
Essilor Stellest glasses are the first eyeglass lenses that are FDA approved for slowing the progression of myopia (nearsightedness) in children 6 to 12 years old at the initiation of treatment. Prior to this, there was only one approved device for slowing the progression of myopia in the form of soft contact lenses or orthokeratology.
All children diagnosed with myopia can now receive myopia control treatment through a simple pair of glasses.
